India to Philippines: Potassium Export Trade Route

The India to Philippines Potassium corridor is one of India's established pharmaceutical export routes, with 1,368 shipments documented worth a combined $45.0M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 21% of all export value, reflecting the consolidated nature of India's potassium manufacturing sector.

Across 106 active suppliers, the average shipment value stands at $32.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with potassium's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 32.5%, placing it at rank #18 among India's top potassium export destinations globally.

On the import side, key buyers of Indian potassium in Philippines include NELPA LIFESCIENCES INC, UNILAB INC, AMBICA INTERNATIONAL CORPORATION and 140 others. NELPA LIFESCIENCES INC is the single largest importer with 73 shipments valued at $11.5M USD.

India's potassium exports to Philippines are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 106 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, GIYAAN PHARMA PRIVATE LIMITED, BDH HEALTHCARE PRIVATE LIMITED — together account for 43% of total trade value on this route. The average shipment value of $32.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, saphlor 50 (losartan potassium tablets usp 50 mg ) (pack 10 x 10 t) and pharmaceutical products harmless medicine, saphlor-100 (losartan potassium tablets usp 100mg) (pack of 24000 x10x10 t), suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NELPA LIFESCIENCES INC is the largest importer with 73 shipments worth $11.5M USD — representing 26% of all potassium imports from India on this route. A total of 143 buyers are active on this corridor.